1944

Grad. Putney Preparatory School, Putney, VT.

1948

B.S., Yale University (Zoology).

1952

M.D, Johns Hopkins University School of Medicine.

1952-1953

Intern in Medicine, Osler Service, Johns Hopkins Hospital.

1953-1955

Medical Officer, USNR: Psychiatric Resident and Hospital Staff Psychiatrist; Division Psychiatrist lst Marine Division Korea. (Letter of Appreciation, Commanding Officer, “Outstanding Performance of Duty”).

1955-1959

Psychiatric Residency, Henry Phipps Psychiatric Clinic, Johns Hopkins Hospital; Fellow in Psychiatry, Johns Hopkins University.

Diplomate National Board of Medical Examiners. Licensed Maryland and California.

Certified by American Board of Psychiatry and Neurology in Psychiatry.

1959-2009
Staff, Dept. of Psychiatry and Behavioral Sciences, Johns Hopkins Hospital.

1959
- Faculty of Medicine, Johns Hopkins University. Associate Professor 1970 to present (Emeritus since 2009).

1961-1973
Physician in charge of Psychiatric Services, Student Health Service, Johns Hopkins University.

1964-l981
Psychiatric Consultant, Office of Disability Programs, Social Security Administration.

1964 – 2015
Private Practice of Psychiatry (Individual, Group, Marital, Family Therapy; Adolescents, Adults).

1966-1973
Attending Staff, Seton Psychiatric Institute. (Executive Coordinating Board l970 -l973).

1970- 2009
Staff (Associate to Honorary), Department of Medicine, Johns Hopkins Hospital.

1972-1974
Director, Psychiatric Outpt. Services & Community Psych. Program, Johns Hopkins Hospital.

1973-1976
Psychiatrist Consultant, University of Notre Dame, Baltimore.

1974-l976
Departmental Council, Dept. of Psychiatry and Behavioral Sciences, Johns Hopkins Hospital.

1974- 2002
Courtesy Staff and Preferred Psychiatrist Affiliate, Dept. of Psychiatry and Medicine, Sheppard and Enoch Pratt Hosp.

1981-1986
Clinical Faculty in the Dept. of Psychology and in the Counseling and Psychiatric Services, Johns Hopkins University, Homewood.

• American Psychiatric Association: Distinguished Life Fellow (Member Assembly of District Branches 1983-1993; APA Nomination Committee 1990-1991; Consultant to APA Task Force on Treatments of Psychiatric Disorders 1989; reviewer, American Journal of Psychiatry 1978-1994.)

• American Medical Association (Life Member)

• American Psychosomatic Society.

• American College of Neuropsychopharmacology.

• American Association for the Advancement of Science (Life Fellow).

• American Association of University Professors.

• Maryland Psychiatric Society (President l978-1979).

• Maryland Foundation for Psychiatry (Board Director 1995-2003; President 2000-2003 ).

• Maryland Interdisciplinary Council for Children and Adolescents (1978-1998)

• Medical and Chirurgical Faculty of the State of Maryland.

• New York Academy of Sciences.

• Baltimore City and Baltimore County Medical Societies.

• Johns Hopkins Medical and Surgical Association.

1. Participation as therapist in Dr. Jerome Frank’s study of placebo effect: 1959.
2. Co-Principal Investigator: Controlled study of the interaction of therapists’ personal characteristics and of medication (imipramine, placebo) in the treatment of depression, USPHS Grant M-3741A: l959-1960. (With E.H. Uhlenhuth, M.D.)
3. Methionine ingestion in schizophrenic patients treated with monoamine oxidase inhibitors, USPHS Grant MH-5521: l96l-l962. (With S.S. Kety, M.D. and R.J. Baldessarini, M.D.)
4. Principal and Co-Principal Investigator: NIMH-PRB Outpatient Study of Drug-Set Interaction, USPHS Grant MH-04732: 1960 1968. (With E.H. Uhlenhuth, M.D. and L. Covi, M.D.)
5. Co-Project Director: A controlled Study of Time-Limited Psychotherapy, USPHS Grant MH-16056: l969-1973. (With E. Meyer, M.D.)
6. Clinical research of borderline and narcissistic conditions: etiology, characteristics and treatment.
7. Psychiatric Research Network, American Psychiatric Assn: 1994-2002.

HIGHLIGHTS

• Park, L.C. and Covi, L. “Non-blind placebo trial: An exploration of neurotic patients’ responses to placebo when its inert content is disclosed.” Arch. Gen. Psychiat. 12:336-345, l965. | Download as PDF
• Park, L.C., Imboden, J.B., Park, T.J., Hulse, S.H. and Unger, H.T. “Giftedness and psychological abuse in borderline personality disorder: Their relevance to genesis and treatment.” Journal of Personality Disorders, 6: 226-240, 1992. | Download as PDF
• Park, L.C. “Does this patient need psychiatric referral? Borderline personality disorder is serious, life-threatening, and fairly common, yet it goes unrecognized by most physicians.” Hospital Medicine, 30: 36-42, l994. [Reprinted in Tiempos Medicos.] | Download as PDF
• Park, L.C. and Park, T.J. “Personal Intelligence.” In McCallum, M. and Piper, W.E. (eds.) Psychological Mindedness: A Contemporary Understanding, Chapter 6, pp. 133-167, 1997 Lawrence Erlbaum Associates, Inc., Mahwah, NJ | Download as PDF
• Park, L.C. “Psychiatry at Johns Hopkins Hospital.” In The Maryland Psychiatric Society: Celebrating 50 Years, pp 36, 42, Maryland Psych. Soc., Baltimore, 2000. | Download as PDF

BOOK

• Park, L. C. and Park, T.J., A New Model for Treating Borderline Personality Disorder, Revised Edition, Herron Creek Press LLC, Phoenicia, NY, 2023. ! Download as PDF
• Allen, T.E., Liebman, M.C., Park, L.C., and Wimmer, W.C., A Primer on Mental Disorders: A Guide for Educators, Families, and Students, Scarecrow Press, Lanham, MD, 2001. | Via Amazon as Kindle, Hardcover, and Paperback

OTHERS 

1. Uhlenhuth, E.H. and Park, L.C. “The influence of medication (imipramine) and doctor in relieving depressed psychoneurotic outpatients. ” J. Psychiat. Res. 2:101-122, 1964.

2. Park, L.C. and Lipman, R.S. “A comparison of patient dosage deviation reports with pill counts.” Psychopharmacologia 6:299 302, l964.

3. Fisher, S., Lipman, R.S., Uhlenhuth, E.H., Rickels, K. and Park, L.C. “Drug effects and initial severity of symptomatology.” Psychopharmacologia 7:57-60, l965.

4. Lipman, R.S., Hammer, H. M., Bernardes, J.F., Park, L.C. and Cole, J.O. “Patient report of significant life situation events: Methodological implications for outpatient drug evaluation.” Dis. Nerv. Syst. 26: 586-591, l965.

5. Park, L.C., Baldessarini, R.J. and Kety, S.S. “Methionine effects on chronic schizophrenics: Patients treated with monoamine oxidase inhibitors.” Arch. Gen. Psychiat. 21:346-351, l965.

6. Uhlenhuth, E.H., Park, L.C., Lipman. R.S., Rickels, K., Fisher, S. and Mock, J.E. “Dosage deviation and drug effects in drug trials.” J. Nerv. Ment. Dis. 141:95-99, l965.

7. Park, L.C., Uhlenhuth, E.H., Lipman, R.S., Rickels, K. and Fisher, S. “A comparison of doctor and patient improvement ratings in a drug (meprobamate) trial.” Brit. J. Psychiat. 111:535-540, l965.

8. Lipman, R.S., Cole, J.O., Park, L.C. and Rickels, K. “Sensitivity of symptom and nonsympton-focused criteria of outpatient drug efficacy.” Amer. J. Psychiat. 122:24-27, l965.

9. Lipman, R.S., Rickels, K., Uhlenhuth, E.H., Park, L.C. and Fisher, S. “Neurotics who fail to take their drugs.” Brit. J. Psychiat. lll: 1042-1049, l965.

10. Uhlenhuth, E.H., Rickels, K., Fisher, S., Park, L.C., Lipman, R.S. and Mock, J.E. “Drug, doctor’s verbal attitude and clinic setting in the symptomatic response to pharmacotherapy.” Psychopharmacologia 9:392-418, l966.

11. Lipman, R.S., Park, L.C. and Rickels, K. “Paradoxical influence of a therapeutic side-effect interpretation.” Arch. Gen. Psychiat. 15:462-474, l966.

12. Park, L.C., Slaughter, R., Covi, L. and Kniffin, H.C., Jr. “The subjective experience of the research patient: An investigation of psychiatric outpatients’ reactions to the research treatment situation.” J. Nerv. Ment. Dis. 143:199-206, l966.

13. Rickels, K., Snow, L., Uhlenhuth, E.H., Lipman, R.S., Park, L.C. and Fisher, S. “Side reactions on meprobamate and placebo.” Dis. Nerv. Syst. 28:39-45, l967.

14. Park, L.C., Covi, L. and Uhlenhuth, E.H. “Effects of informed consent on research patients and study results.” J. Nerv. Ment. Dis., l45:349-357, l967.

15. Uhlenhuth, E.H., Lipman, R.S., Rickels, K., Fisher, S., Covi, L., and Park, L.C. “Predicting the relief of anxiety with meprobamate: Non-drug factors in the response of psychoneurotic outpatients.” Arch. Gen. Psychiat., 19:619-630, l968.

16. Uhlenhuth, E.H., Duncan, D.B. and Park, L.C. “Some nonpharmacologic modifiers of the response to imipramine in depressed psychoneurotic outpatients: A confirmatory study.” In May, P.R.A. and Wittenborn, J.R. (eds.) Psychotropic Drug Response: Advances in Prediction, pp. 155-197, Charles C. Thomas, Springfield, IL., l969.

17. Covi, L., Park, L.C., Lipman, R.S., Uhlenhuth, E.H. and Rickels, K. “Factors affecting withdrawal response to certain minor tranquilizers.” In Cole, J.O. and Wittenborn, J.R. (eds.) Drug Abuse: Social and Psychopharmacological Aspects, pp. 93-108, Charles C. Thomas, Springfield, IL., l969.

18. Rickels, K., Howard, K., Lipman, R.S., Covi, L., Park, L.C. and Uhlenhuth, E.H. “Differential reliability in rating psychopathology and global improvement.” J. Clin. Psychol., 26:320-323, l970.

19. Imboden, J.B. and Park, LC. “Dissociative Reactions.” In Tice’s Practice of Medicine, Vol. 10, Chapter 38, pp. l9-24, Harper and Row, Hagerstown, MD., l970.

20. Rickels, K., Lipman, R.S., Fisher, S., Park, L.C. and Uhlenhuth, E.H. “Is a double-blind clinical trial really double blind? A report of doctors’ medication guesses.” Psychopharmacologia, 16:329-336, l970.

21. Park, L.C. and Imboden, J.B. “Clinical and heuristic value of clinical drug research.” J. Nerv. Ment. Dis., 151:322-340, l970.

22. Rickels, K., Lipman, R.S., Park, L.C., Covi, L., Uhlenhuth, E.H. and Mock, J.E. “Drug, doctor warmth, and clinic setting in the symptomatic response to minor tranquilizers.” Psychopharmnacologia, 20: 128-152, l97l.

23. Uhlenhuth. E.H., Covi, L., Rickels, K., Lipman, R.S. and Park, L.C. “Predicting the relief of anxiety with meprobamate: An attempt at replication.” Arch. Gen. Psychiat., 26: 85-91, l972.

24. Park, L.C. “What limitations should exist on psychiatric evaluations of individuals done for government and other third parties?” The Maryland Psychiatrist, 1:2, l974.

25. Meyer, E., Derogatis, L.R., Miller, J.M. Park, L.C. and Whitmarsh, G.A. “Medical Clinic patients with emotional disorders.” Psychosomatics, 19:611-619,l978.

26. Meyer, E., Derogatis, L.R., Miller, M.J., Reading, A.J., Cohen, I.H., Park, L.C. and Whitmarsh, G.A. “Addition of time limited psychotherapy to medical treatment in a general medical clinic.” J.Nerv. Ment. Dis., 169:780-790, l98l.

27. Imboden, J.B. and Park, L.C. “Conversion Reactions.” In Spittell, J.A., Jr. (ed.) Clinical Medicine, Chapter 35, pp.l-5, Harper and Row, Philadelphia, PA. l98l.

28. Park, L.C. and Imboden, J.B. “Dissociative Reactions.” In Spittell, J.A., Jr. (ed.) Clinical Medicine, Chapter 36, pp. l-5, Harper and Row, Philadelphia, PA., l98l.

29. Park, L.C. “The APA Assembly in Action.” Maryland Psychiatric Society News, 2:2-3, 1988.

30. Park, L.C. “Positive outlook enhances `golden years’.” Senior Digest, 13:18, 1989.

31. Park, L.C. “Psychiatry ignoring child abuse and neglect movement.” Psychiatric News, 27:14, l992.